Retracing changes in cystic fibrosis understanding and management over the past twenty years

被引:4
作者
Ratjen, Felix [1 ,2 ]
VanDevanter, Donald R. [3 ]
机构
[1] Hosp Sick Children, Div Resp Med, Dept Paediat, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA
关键词
PSEUDOMONAS-AERUGINOSA INFECTION; INHALED HYPERTONIC SALINE; CLINICAL-TRIALS NETWORK; CF; AZITHROMYCIN; TOBRAMYCIN; CHILDREN; FOUNDATION; GUIDELINES; IVACAFTOR;
D O I
10.1016/j.jcf.2021.09.015
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:3 / 9
页数:7
相关论文
共 66 条
  • [21] From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
    Gramegna, Andrea
    Contarini, Martina
    Aliberti, Stefano
    Casciaro, Rosaria
    Blasi, Francesco
    Castellani, Carlo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 23
  • [22] Grosse Scott D., 2004, Morbidity and Mortality Weekly Report, V53, P1
  • [23] Hewer SCL, 2020, LANCET RESP MED, V8, P975, DOI 10.1016/S2213-2600(20)30331-3
  • [24] Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis
    Hoegger, Mark J.
    Fischer, Anthony J.
    McMenimen, James D.
    Ostedgaard, Lynda S.
    Tucker, Alex J.
    Awadalla, Maged A.
    Moninger, Thomas O.
    Michalski, Andrew S.
    Hoffman, Eric A.
    Zabner, Joseph
    Stoltz, David A.
    Welsh, Michael J.
    [J]. SCIENCE, 2014, 345 (6198) : 818 - 822
  • [25] The Microbiome in Cystic Fibrosis
    Huang, Yvonne J.
    LiPuma, John J.
    [J]. CLINICS IN CHEST MEDICINE, 2016, 37 (01) : 59 - +
  • [26] Epidemiology of CF: How registries can be used to advance our understanding of the CF population
    Jackson, Abaigeal D.
    Goss, Christopher H.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (03) : 297 - 305
  • [27] Airway Infection with a Novel Cupriavidus Species in Persons with Cystic Fibrosis
    Kalka-Moll, Wiltrud Maria
    LiPuma, John J.
    Accurso, Frank J.
    Plum, Georg
    van Koningsbruggen, Silke
    Vandamme, Peter
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (09) : 3026 - 3028
  • [28] Knapp EA, 2016, ANN AM THORAC SOC, V13, P1173, DOI 10.1513/AnnalsATS.201511-781OC
  • [29] Cystic fibrosis - Cost of illness and considerations for the economic evaluation of potential therapies
    Krauth, C
    Jalilvand, N
    Welte, T
    Busse, R
    [J]. PHARMACOECONOMICS, 2003, 21 (14) : 1001 - 1024
  • [30] The Changing Microbial Epidemiology in Cystic Fibrosis
    LiPuma, John J.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2010, 23 (02) : 299 - +